Shenzhen Lihexing Co. Ltd.
Shenzhen Lihexing Co.,Ltd. engages in the research and development, production, and sale of automation and intelligent equipment for information and communication technology industry in China. It provides stud welding equipment used in automatically soldering studs and shielding sheets to the middle frame of the phone using laser technology; AMOLED assembly equipment for covering OLED flexible sc… Read more
Shenzhen Lihexing Co. Ltd. (301013) - Total Liabilities
Latest total liabilities as of September 2025: CN¥777.93 Million CNY
Based on the latest financial reports, Shenzhen Lihexing Co. Ltd. (301013) has total liabilities worth CN¥777.93 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Shenzhen Lihexing Co. Ltd. - Total Liabilities Trend (2013–2024)
This chart illustrates how Shenzhen Lihexing Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Shenzhen Lihexing Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Shenzhen Lihexing Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tactile Systems Technology Inc
NASDAQ:TCMD
|
USA | $54.23 Million |
|
Molson Coors Canada Inc
TO:TPX-B
|
Canada | CA$12.20 Billion |
|
Shaanxi Heimao Coking Co Ltd
SHG:601015
|
China | CN¥11.98 Billion |
|
Medincell SA
PA:MEDCL
|
France | €105.21 Million |
|
FirstSun Capital Bancorp Common Stock
OTCQX:FSUN
|
USA | $7.37 Billion |
|
Arbutus Biopharma Corp
NASDAQ:ABUS
|
USA | $20.31 Million |
|
Shandong Jincheng Pharmaceutical and Chemical Co Ltd
SHE:300233
|
China | CN¥1.42 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Shenzhen Lihexing Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.50 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shenzhen Lihexing Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shenzhen Lihexing Co. Ltd. (2013–2024)
The table below shows the annual total liabilities of Shenzhen Lihexing Co. Ltd. from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥690.18 Million | +4.37% |
| 2023-12-31 | CN¥661.28 Million | +31.20% |
| 2022-12-31 | CN¥504.01 Million | +26.35% |
| 2021-12-31 | CN¥398.89 Million | +111.98% |
| 2020-12-31 | CN¥188.17 Million | -36.87% |
| 2019-12-31 | CN¥298.07 Million | +45.55% |
| 2018-12-31 | CN¥204.79 Million | +107.18% |
| 2017-12-31 | CN¥98.85 Million | +15.83% |
| 2016-12-31 | CN¥85.34 Million | +51.80% |
| 2015-12-31 | CN¥56.22 Million | +75.38% |
| 2014-12-31 | CN¥32.05 Million | +312.13% |
| 2013-12-31 | CN¥7.78 Million | -- |